欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/1107/001
药品名称Levosimendan Altan 2.5 mg/ml concentrate for solution for infusion
活性成分
    • levosimendan 2.5 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Altan Pharma ltd The Lennox Building 50 South Richmond Street D02 FK02 Dublin, Ireland
参考成员国 - 产品名称Austria (AT)
Levosimendan Altan 2,5 mg/ml Konzentrat zur Herstellung einer Infusionslösung
互认成员国 - 产品名称
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
      Levosimendan Altan
    • Finland (FI)
    • Poland (PL)
    • Germany (DE)
      Levosimendan 2,5 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • Belgium (BE)
      Levosimendan Altan 2,5 mg/ml solution à diluer pour perfusion
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
许可日期2021/03/08
最近更新日期2024/09/04
药物ATC编码
    • C01CX08 levosimendan
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase